Stocks To Buy Now

Blog


Hemp, Inc. (HEMP): Q3 Sales Increase 58% Over Q2 Performance

hemp

Hemp, Inc., today announced a 58.3-percent increase in third-quarter sales for the period ended September 30, 2015, as compared to the second quarter.

“The industrial hemp industry is really booming. More states are beginning to realize it is more advantageous for them to legalize it. As you know, North Carolina, home to our industrial hemp commercial decortication facility, legalized hemp. Farmers in North Carolina now have the option to cultivate hemp crops with easy access to Hemp, Inc.’s (OTC PINK: HEMP) multipurpose industrial hemp commercial processing facility,” Hemp, Inc. CEO Bruce Perlowin stated in the news release.

Hemp, Inc. calls the legalization of industrial hemp in North Carolina a “game changer” for the company, directing it toward more advanced processing in the milling line. Perlowin said the company will continue to market its hemp-based cosmeceutical and nutraceutical product line and that “In terms of generating profit, our multipurpose industrial hemp processing facility in Spring Hope, North Carolina, by far outweighs any sales revenue generated from our product line, which is why we feel it best to shift focus.”

As the industry continues to grow, Hemp, Inc. said it expects to generate millions of dollars per year pending the completion of its multipurpose industrial hemp processing plant that vertically integrates growing, decortification, milling, and more.

For more information visit www.hempinc.com

Let us hear your thoughts: Hemp, Inc. Message Board

From Our Blog

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Clinical and Regulatory Milestones

July 28, 2026

Cartilage Regeneration Gains Strategic Validation The orthopedic industry is increasingly focused on technologies that can address cartilage damage by promoting tissue regeneration rather than simply managing symptoms. This opportunity gained additional validation when Smith+Nephew completed its acquisition of CartiHeal, a developer of cartilage repair technology, in a transaction valued at up to $330 million. The […]

Rotate your device 90° to view site.